The Company has received an order from New York -based Company for supply of body care products for a value aggregating to 150 lakhs
ORDERS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 11 Apr 2026, 12:53 PM IST · BSE ID: 9d91c635-4c2a-42de-8d1f-c7b6ffadcb03
View Original BSE Filing (PDF)
💡
In Simple Terms
The company just won a Rs. 150 lakhs export order from a New York company for personal care products, to be delivered within 45 days.
🤖 AI Summary
- Veerhealth Care secured Rs. 150 lakhs export order from New York-based company
- Order value: USD 1,60,650 (approximately Rs. 150 lakhs) for body care products
- International order with FOB NHava Seva terms, 45-day execution period
- No promoter interest in awarding entity; arm's length transaction confirmed
- Follows Rs. 5.50 Crore domestic FMCG order announced 20 March 2026
🔢 Key Numbers — exact figures from BSE filing, not rounded
Order value
Rs. 150 lakhs (USD 1,60,650)
Execution timeline
45 days
Prior domestic order (20 March 2026)
Rs. 5.50 Crore
🏢 How This Affects the Company
Order adds to export revenue pipeline. Combined with Rs. 5.50 Crore domestic order from March 2026, company demonstrates order flow momentum across geographies.
Rs. 150 lakhs order will contribute to topline revenue upon 45-day execution completion. Cash inflow timing dependent on customer payment terms post-delivery.
45-day execution window requires capacity planning for body care product manufacturing and FOB shipment logistics via port.
International order introduces FX exposure and customer concentration risk. Customer name undisclosed per confidentiality terms limits visibility on counterparty creditworthiness.
👥 What This Means For Shareholders
✅
Action Required
No action required. Monitor Q4 FY26 results filing to confirm order execution and revenue recognition.
👤
Who Is Affected
All shareholders benefit from diversified order base across domestic and international customers. Revenue concentration risk reduces if order inflow sustains.
🔍
Management Signal
Management actively pursuing both domestic FMCG partnerships and export opportunities, signaling growth intent beyond domestic market.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q4 FY26 results filing — verify order executed and revenue recognized within 45 days
Management commentary on order flow pipeline and customer diversification strategy
Next quarter order announcements to assess repeat customer business or new customer acquisition
MEDIUM RISK
Customer identity undisclosed; international currency and payment terms create FX and credit risk; 45-day execution window is tight.
💡 Investor Takeaway
Veerhealth Care secured Rs. 150 lakhs export order within 22 days of announcing Rs. 5.50 Crore domestic order. Two orders in rapid succession confirm sales traction, though international order size trails domestic contract. Execution within 45 days will confirm operational capability.
⚖️ Strengths & Concerns
✅ Positives
- Two orders secured in 22 days (March 20 and April 11) demonstrates sales momentum and market traction.
- International order validates export capability and product quality appeal to overseas markets.
⚠️ Concerns
- Order value of Rs. 150 lakhs is modest relative to Rs. 5.50 Crore domestic order received 22 days prior.
📅 Company Track Record
On 20 March 2026, Veerhealth Care announced Rs. 5.50 Crore order from major domestic FMCG company, representing 76% of Q3 FY26 revenue. This April 11 order for Rs. 150 lakhs follows within 22 days, adding to order momentum but indicating smaller deal size for export.
Based on publicly available historical data. For context only.